Along with the current clinical trial, the efficacy and safety of 180 mg loading dose of
ticagrelor administered within 12 hours of first-ever ischemic stroke compared to 300 mg
clopidogrel were assessed through NIHSS, mRS, duration of hospital stay, and possible adverse
effects.